Report Scope & Overview:
Omega-3 Fatty Acid Market Size was valued at USD 2.35 billion in 2022 and is expected to reach USD 4.16 billion by 2030, and grow at a CAGR of 7.4% over the forecast period 2023-2030.
Fish and flaxseed, as well as vitamin supplements like fish oil, contain omega-3 fatty acids. The three principal omega-3 unsaturated fats are alpha-linolenic corrosive (ALA), eicosapentaenoic corrosive (EPA), and docosahexaenoic corrosive (DHA). DHA and EPA are found in fish and other seafood, while alpha-linolenic acid (ALA) is found in plant oils such as soybean, flaxseed, and canola oils. Omega-3 fatty acids play a crucial role in the human body because they are important components of the membranes that surround each cell. They also act as a source of calories, providing energy to the body and aiding in numerous biological activities.
The omega-3 Fatty acids is being driven by the advent of omega-3 as an active pharmaceutical ingredient (API) and the growing awareness of chronic diseases among people all over the world. The adoption of favorable rules regarding the use of omega-3 in infant formulas, as well as cooperation between key companies to improve the product, are accelerating the growth of omega-3 fatty acids. Increased adoption of omega-3 in supplements and functional foods as it is known to be highly effective in the treatment of a variety of health problems like menstrual health, depression, mental health, and bone loss, as well as an increase in demand for food fortification, particularly for mother and infant nutrition products, all, have an impact on the omega-3 fatty acids market.
Moreover, expanded consciousness of omega-3's wellbeing benefits, use in pet food and feed, a more noteworthy spotlight on deterrent medical care, development in food handling applications, and rising medical services use all lift the omega-3 unsaturated fat industry. Moreover, in the forecast period, innovative production technologies, development of alternative sources of omega-3, microencapsulation, growing awareness of certified food ingredients, favorable regulatory environment, and enhancing consumer demand for plant-based products provide profitable opportunities for omega-3 fatty acids market players.
Increasing awareness of health benefit
Advancement in technologies
Unpleasant sensory experience.
High investment in extraction of omega-3
Competitive price range.
Large or scare competition
IMPACT OF COVID-19
The COVID-19 outbreak has helped the international market. There has been a significant surge in demand for omega fatty acid foods and dietary supplements to improve health and immunity, according to research. The widespread dissemination of doctor recommendations to incorporate immunity-boosting dietary supplements into daily living is a major factor in the product's widespread adoption. The supply chains of enterprises in the industry have been disrupted, owing to mobility limitations and geometrically rising logistics and transportation costs as a result of the ongoing pandemic. The product's manufacturing process has been hampered by a slowdown in the import and production of raw materials.
Furthermore, the original lockdowns, as well as their persistence, have resulted in workforce shortages in some manufacturing plants. From now on, product safety, product information transparency, and cleanliness issues are expected to stay prevalent among consumers. Market participants can raise their market value and prominence by ensuring the aforementioned variables are completely addressed during raw material sourcing, product manufacture, and packaging.
By Type: Alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) make up the omega-3 market (DHA).
By Source: Fish oil and krill oil, algal oil, walnut, pumpkin seeds, soybean oil, canola oil, bean curd, and other omega-3 products are available.
By Application: Dietary supplements, pharmaceuticals, infant formula, food and beverage, pet food, and fish feed are all segments of the omega-3 market.
Orkla Health, BASF SE, Aker Biomarine Antarctic AS, EPAX, BioProcess Algae, LLC, Lonza, Croda International Plc, Omega Protein Corp., Koninklijke DSM N.V., GC Reiber Oils.
KEY MARKET SEGMENTS:
Soya and Soya Products
Nuts and Seeds
ALA (alpha-linolenic acid)
EPA (eicosapentaenoic acid)
DHA (docosahexaenoic acid)
Food & Beverage
North America was the largest regional market. Several regional market players, including Omega Protein Corp., Martek Biosciences Corp., and BioProcess Algae, are focused on R&D activities to create pharma-grade omega 3, which is boosting the regional market growth. The growing demand for omega 3 supplements in Europe can be ascribed to an aging population and an increase in cases of various health disorders, notably in economies.
Over the forecast period, Asia Pacific is expected to have the highest CAGR. Growing awareness of the need for a healthy diet and general well-being, as well as rising disposable income, are predicted to enhance product demand in the region. In the Asia Pacific, the high birth rate and growing population of young mothers are expected to increase demand for baby nourishment, resulting in increased product consumption. Brazil, with increased demand for health supplements, is driving product demand throughout Central and South America.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of the Middle East & Africa
Rest of Latin America
|Market Size in 2022||US$ 2.35 Billion|
|Market Size by 2030||US$ 4.16 Billion|
|CAGR||CAGR of 7.4% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Source (Marine, Vegetable oils, Soya and Soya Products, Nuts and Seeds)
• By Type (ALA, EPA, DHA)
• By Application (Dietary Supplement, Food & Beverage, Fish Feed, Pharmaceutical, Infant Formula, Pet Food)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Orkla Health, BASF SE, Aker Biomarine Antarctic AS, EPAX, BioProcess Algae, LLC, Lonza, Croda International Plc, Omega Protein Corp., Koninklijke DSM N.V., GC Reiber Oils.|
|DRIVERS||• Increasing awareness of health benefit
• Advancement in technologies
|Restraints||• Unpleasant sensory experience.
• High temperatures
• Quality effects
The size of the Omega-3 Fatty Acid Market Size was valued at USD 2.19 billion in 2021.
Unpleasant sensory experience, and High temperatures are the restraint of the market.
North America was the largest regional market.
Five steps are followed while doing the research process. The first is secondary research, the second is primary research, the third is data bank validation, the fourth QA/QC process, and the fifth final QC/QA process.
Yes, data validation process is followed in this report.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
22.214.171.124 United Kingdom
126.96.36.199 South Korea
188.8.131.52 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Omega-3 Fatty Acid Market Segmentation, by Source
8.2 Vegetable oils
8.3 Soya and Soya Products
8.4 Nuts and Seeds
9. Omega-3 Fatty Acid Market Segmentation, by Type
9.1 ALA (alpha-linolenic acid)
9.2 EPA (eicosapentaenoic acid)
9.3 DHA (docosahexaenoic acid)
10. Omega-3 Fatty Acid Market Segmentation, By Application
10.1 Dietary Supplement
10.2 Food & Beverage
10.3 Fish Feed
10.5 Infant Formula
10.6 Pet Food
11. Regional Analysis
11.2 North America
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4.2 South Korea
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.3 South Africa
11.6 Latin America
11.6.3 Rest of Latin America
12. Company Profiles
12.1 Orkla Health
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 BASF SE
12.3 Aker Biomarine Antarctic AS
12.5 BioProcess Algae, LLC
12.6 Lonza, Croda International Plc
12.7 Omega Protein Corp.
12.8 Koninklijke DSM N.V.
12.9 GC Reiber Oils.
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Blood Grouping Reagents Market Size was valued at USD 1.90 billion in 2022, and expected to reach USD 4.11 billion by 2030, and grow at a CAGR of 10.1% over the forecast period 2023-2030.
The Ion Chromatography Market Size was valued at USD 2.75 billion in 2022, and expected to reach USD 5.49 billion by 2030, and grow at a CAGR of 9% over the forecast period 2023-2030.
The Digital Hearing Aids Market is expected to grow at a CAGR of 7% during the forecasted period 2023-2030.
Report Scope & Overview: Neurorehabilitation Market Size was assessed at USD 1.29 billion in 2
Hi! Click one of our member below to chat on Phone